Product Name

  • Name

    Bosentan

  • EINECS 643-099-1
  • CAS No. 147536-97-8
  • Article Data49
  • CAS DataBase
  • Density 1.326 g/cm3
  • Solubility
  • Melting Point 171-175°C(lit.)
  • Formula C27H29N5O6S
  • Boiling Point 742.3 ºC at 760 mmHg
  • Molecular Weight 551.623
  • Flash Point 402.8 ºC
  • Transport Information
  • Appearance pale yellow to off-white solid
  • Safety
  • Risk Codes R36; R43
  • Molecular Structure Molecular Structure of 147536-97-8 (Bosentan)
  • Hazard Symbols Xi
  • Synonyms Actelion;Ro 47-0203;Ro 47-0203/039;Tracleer;p-tert-Butyl-N-[6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzenesulfonamide;Benzenesulfonamide,4-(1,1-dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-;
  • PSA 154.03000
  • LogP 5.35770

Synthetic route

ethylene glycol
107-21-1

ethylene glycol

4-tert-butyl-N-(6-chloro-5-(2-methoxyphenoxy)2,2'-bipyrimidin-4-yl)benzene sulfonamide
150727-06-3

4-tert-butyl-N-(6-chloro-5-(2-methoxyphenoxy)2,2'-bipyrimidin-4-yl)benzene sulfonamide

bosentan
147536-97-8

bosentan

Conditions
ConditionsYield
Stage #1: ethylene glycol; 4-tert-butyl-N-(6-chloro-5-(2-methoxyphenoxy)2,2'-bipyrimidin-4-yl)benzene sulfonamide With sodium hydroxide In tetrahydrofuran at 60 - 65℃; for 12h;
Stage #2: With tartaric acid In tetrahydrofuran; water at 5 - 10℃; for 1h;
95.7%
With sodium hydroxide In tetrahydrofuran at 50 - 65℃; for 7h; Time;92%
Stage #1: ethylene glycol; 4-tert-butyl-N-(6-chloro-5-(2-methoxyphenoxy)2,2'-bipyrimidin-4-yl)benzene sulfonamide With sodium hydroxide at 100℃; for 2h;
Stage #2: With DL-tartaric acid In tetrahydrofuran; water Reagent/catalyst; Cooling with ice;
88.3%
N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-yl-pyrimidin-4-yl]-4-tert-butylbenzenesulphonamide sodium salt

N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-yl-pyrimidin-4-yl]-4-tert-butylbenzenesulphonamide sodium salt

bosentan
147536-97-8

bosentan

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water at 20 - 30℃; for 3h;95%
With hydrogenchloride In ethanol; water pH=3;116 g
4-[(1,1-dimethylethyl)-N-[6-(2-formyloxy)ethoxy]-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]benzenesulfonamide

4-[(1,1-dimethylethyl)-N-[6-(2-formyloxy)ethoxy]-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]benzenesulfonamide

bosentan
147536-97-8

bosentan

Conditions
ConditionsYield
Stage #1: 4-[(1,1-dimethylethyl)-N-[6-(2-formyloxy)ethoxy]-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]benzenesulfonamide With water; sodium hydroxide In ethanol at 25 - 30℃; for 1h;
Stage #2: With hydrogenchloride In ethanol; water for 1h; pH=5.5;
93%
Stage #1: 4-[(1,1-dimethylethyl)-N-[6-(2-formyloxy)ethoxy]-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]benzenesulfonamide With sodium hydroxide In water at 25℃; for 1h;
Stage #2: In ethanol Reflux;
91.2%
bosentan p-toluenesulfonate

bosentan p-toluenesulfonate

bosentan
147536-97-8

bosentan

Conditions
ConditionsYield
With sodium hydrogencarbonate In ethanol; water at 20 - 25℃; for 1h;93%
4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl]benzene-1-sulfonamide potassium salt

4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl]benzene-1-sulfonamide potassium salt

bosentan
147536-97-8

bosentan

Conditions
ConditionsYield
With hydrogenchloride In water; isopropyl alcohol at 20℃; for 3h;90%
With hydrogenchloride In water; 4-methyl-2-pentanone at 75℃; Inert atmosphere;
With hydrogenchloride In water; 4-methyl-2-pentanone at 75℃;
With hydrogenchloride In water32 g
trifluoromethanesulfonic acid 2-[6-(4-tert-butylbenzenesulfonylamino)-5-(2-methoxyphenoxy)-[2,2']bipyrimidinyl-4-yloxy]ethyl ester
1334686-08-6

trifluoromethanesulfonic acid 2-[6-(4-tert-butylbenzenesulfonylamino)-5-(2-methoxyphenoxy)-[2,2']bipyrimidinyl-4-yloxy]ethyl ester

bosentan
147536-97-8

bosentan

Conditions
ConditionsYield
Stage #1: trifluoromethanesulfonic acid 2-[6-(4-tert-butylbenzenesulfonylamino)-5-(2-methoxyphenoxy)-[2,2']bipyrimidinyl-4-yloxy]ethyl ester With ethanol; sodium hydroxide at 20℃; for 1h;
Stage #2: With hydrogenchloride In dichloromethane; water at 0℃; pH=3 - 3.5;
90%
Stage #1: trifluoromethanesulfonic acid 2-[6-(4-tert-butylbenzenesulfonylamino)-5-(2-methoxyphenoxy)-[2,2']bipyrimidinyl-4-yloxy]ethyl ester With sodium hydroxide In ethanol at 20℃; for 1h;
Stage #2: With hydrogenchloride In ethanol; dichloromethane; water pH=3 - 3.5;
90%
4-tert-butyl-N-[6-chloro-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzene sulfonamide potassium salt

4-tert-butyl-N-[6-chloro-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzene sulfonamide potassium salt

ethylene glycol
107-21-1

ethylene glycol

bosentan
147536-97-8

bosentan

Conditions
ConditionsYield
Stage #1: ethylene glycol With potassium carbonate In acetonitrile for 0.25h;
Stage #2: 4-tert-butyl-N-[6-chloro-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzene sulfonamide potassium salt In acetonitrile at 80 - 85℃; for 12h; Temperature; Time; Solvent;
89%
Stage #1: ethylene glycol With sodium hydroxide In acetonitrile at 75 - 80℃; for 8 - 12h;
Stage #2: 4-tert-butyl-N-[6-chloro-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzene sulfonamide potassium salt In acetonitrile for 12 - 14h;
Stage #3: With hydrogenchloride; water In acetonitrile at 25℃; for 2h; pH=2 - 3; Product distribution / selectivity;
Stage #1: 4-tert-butyl-N-[6-chloro-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzene sulfonamide potassium salt; ethylene glycol With barium(II) hydroxide In toluene at 110℃;
Stage #2: With hydrogenchloride In water pH=1 - 2; Product distribution / selectivity;
4-tert-butyl-N-(5-(2-methoxyphenoxy)-6-(2-(tetrahydro-2H-pyran-2-yloxy)ethoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide

4-tert-butyl-N-(5-(2-methoxyphenoxy)-6-(2-(tetrahydro-2H-pyran-2-yloxy)ethoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide

bosentan
147536-97-8

bosentan

Conditions
ConditionsYield
With pyridinium p-toluenesulfonate In methanol at 20℃; for 24h; Inert atmosphere;84%
bosentan potassium
1174918-31-0

bosentan potassium

bosentan
147536-97-8

bosentan

Conditions
ConditionsYield
With hydrogenchloride In dichloromethane; water at 20 - 30℃; pH=0.5 - 1;80.8%
4-tert-butyl-N-(5-(2-methoxyphenoxy)-6-(2-oxoethoxy)-2,2′-bipyrimidin-4-yl)benzenesulfonamide
1174918-30-9

4-tert-butyl-N-(5-(2-methoxyphenoxy)-6-(2-oxoethoxy)-2,2′-bipyrimidin-4-yl)benzenesulfonamide

bosentan
147536-97-8

bosentan

Conditions
ConditionsYield
With sodium tetrahydroborate In methanol at 0 - 5℃; Solvent;80%
With sodium tetrahydroborate In methanol at 0 - 20℃;80%
With sodium tetrahydroborate In methanol at 0 - 5℃;75%
Stage #1: 4-tert-butyl-N-(5-(2-methoxyphenoxy)-6-(2-oxoethoxy)-2,2′-bipyrimidin-4-yl)benzenesulfonamide With sodium tetrahydroborate In methanol at 0 - 5℃; for 2h;
Stage #2: With hydrogenchloride In methanol; water pH=2; Product distribution / selectivity;
With methanol; sodium tetrahydroborate for 4h;
2,2-dimethyl-propionic acid 2-[6-(4-tert-butyl-benzenesulfonylamino)-5-(2-methoxy-phenoxy)-[2,2']-bipyrimidinyl-4-yloxy]-ethyl ester
1374293-39-6

2,2-dimethyl-propionic acid 2-[6-(4-tert-butyl-benzenesulfonylamino)-5-(2-methoxy-phenoxy)-[2,2']-bipyrimidinyl-4-yloxy]-ethyl ester

bosentan
147536-97-8

bosentan

Conditions
ConditionsYield
Stage #1: 2,2-dimethyl-propionic acid 2-[6-(4-tert-butyl-benzenesulfonylamino)-5-(2-methoxy-phenoxy)-[2,2']-bipyrimidinyl-4-yloxy]-ethyl ester With water; sodium hydroxide In ethanol at 10 - 25℃;
Stage #2: With hydrogenchloride In ethanol; water at 10 - 15℃; for 2h;
80%
ethyl 2-(6-(4-tert-butylphenylsulfonamido)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yloxy)acetate

ethyl 2-(6-(4-tert-butylphenylsulfonamido)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yloxy)acetate

bosentan
147536-97-8

bosentan

Conditions
ConditionsYield
With sodium tetrahydroborate In methanol at 0 - 5℃;80%
4-tert-butyl-N-[6-(2-hydroxyethoxy)-2-iodo-5-(2-methoxyphenoxy)-pyrimidin-4-yl]-benzenesulfonamide
1206769-86-9

4-tert-butyl-N-[6-(2-hydroxyethoxy)-2-iodo-5-(2-methoxyphenoxy)-pyrimidin-4-yl]-benzenesulfonamide

2-(tributylstannyl)pyrimidine
153435-63-3

2-(tributylstannyl)pyrimidine

bosentan
147536-97-8

bosentan

Conditions
ConditionsYield
With cesium fluoride; bis(tri-t-butylphosphine)palladium(0) In 1,4-dioxane at 100 - 110℃; for 16h; Inert atmosphere;70%
trifluoromethanesulfonic acid 4-(2-tert-butoxyethoxy)-6-(4-tert-butylbenzenesulfonylamino)-5-(2-methoxyphenoxy)pyrimidin-2-yl ester
1334686-05-3

trifluoromethanesulfonic acid 4-(2-tert-butoxyethoxy)-6-(4-tert-butylbenzenesulfonylamino)-5-(2-methoxyphenoxy)pyrimidin-2-yl ester

2-(tributylstannyl)pyrimidine
153435-63-3

2-(tributylstannyl)pyrimidine

bosentan
147536-97-8

bosentan

Conditions
ConditionsYield
tetrakis(triphenylphosphine) palladium(0) In N,N-dimethyl acetamide at 130℃; for 6h; Stille Coupling;70%
tetrakis(triphenylphosphine) palladium(0) In ISOPROPYLAMIDE at 130℃; for 6h;70%
N-[6-[2-(1,1-dimethylethoxy)ethoxy]-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)benzenesulfonamide

N-[6-[2-(1,1-dimethylethoxy)ethoxy]-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)benzenesulfonamide

bosentan
147536-97-8

bosentan

Conditions
ConditionsYield
Stage #1: N-[6-[2-(1,1-dimethylethoxy)ethoxy]-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)benzenesulfonamide With formic acid at 85℃; for 1.5h;
Stage #2: With potassium carbonate In methanol for 1h;
70%
Stage #1: N-[6-[2-(1,1-dimethylethoxy)ethoxy]-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)benzenesulfonamide With formic acid at 85℃; for 1.5h;
Stage #2: With potassium carbonate In methanol for 1h;
Stage #3: With hydrogenchloride In methanol; water; ethyl acetate pH=3 - 3.5;
70%
With phosphoric acid In acetonitrile at 25℃; Product distribution / selectivity; Reflux;
Multi-step reaction with 2 steps
1.1: 4 h / 85 °C
2.1: sodium hydroxide / water / 1 h / 25 °C
2.2: Reflux
View Scheme
N-[2-bromo-6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-pyrimidin-4-yl]-4-tert-butyl-benzenesulfonamide
1206769-81-4

N-[2-bromo-6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-pyrimidin-4-yl]-4-tert-butyl-benzenesulfonamide

2-(tributylstannyl)pyrimidine
153435-63-3

2-(tributylstannyl)pyrimidine

bosentan
147536-97-8

bosentan

Conditions
ConditionsYield
With cesium fluoride; bis(tri-t-butylphosphine)palladium(0) In N,N-dimethyl-formamide at 140 - 150℃; for 16h; Inert atmosphere;47%
2-(5-(2-methoxy-phenoxy)-6-chloro-2-(pyrimidin-2-yl)pyrimidin-4-yloxy) ethanol
184779-15-5

2-(5-(2-methoxy-phenoxy)-6-chloro-2-(pyrimidin-2-yl)pyrimidin-4-yloxy) ethanol

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

bosentan
147536-97-8

bosentan

Conditions
ConditionsYield
With potassium phosphate; copper(l) iodide; glycine In 1,4-dioxane at 120℃; for 44h; Product distribution / selectivity;31%
With potassium phosphate; copper(l) iodide; glycine In 1,4-dioxane at 120℃; for 44h; Product distribution / selectivity;31%
With potassium phosphate In N,N-dimethyl acetamide at 20 - 100℃; for 18h; Product distribution / selectivity;
With potassium carbonate; tetrabutylammomium bromide In toluene at 100 - 110℃; for 15h;
ethylene glycol
107-21-1

ethylene glycol

4,6-dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine
150728-13-5

4,6-dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine

potassium 4-tert-butylbenzenesulfonate

potassium 4-tert-butylbenzenesulfonate

bosentan
147536-97-8

bosentan

Conditions
ConditionsYield
With sodium 1.) DMSO, rt, 2.) 100 deg C; Multistep reaction;
5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl) pyrimidine-4,6(1H, 5H)-dione
150728-12-4

5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl) pyrimidine-4,6(1H, 5H)-dione

bosentan
147536-97-8

bosentan

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: POCl3, PCl5 / Heating
2: 2.) Na / 1.) DMSO, rt, 2.) 100 deg C
View Scheme
Multi-step reaction with 5 steps
1.1: trichlorophosphate / 4 h / Reflux
2.1: potassium hydroxide / acetone / 0.08 h / 30 °C
2.2: 6.5 h / 30 °C / Reflux
3.1: sodium hydride / N,N-dimethyl-formamide; mineral oil / 30 - 50 °C
3.2: 0.5 h / 30 °C
4.1: hydrogenchloride; water / 1 h
5.1: sodium tetrahydroborate; methanol / 4 h
View Scheme
Multi-step reaction with 5 steps
1.1: trichlorophosphate / 90 - 105 °C
2.1: potassium carbonate; tetrabutylammomium bromide / toluene / 50 °C / Reflux; Dean-Stark
3.1: sodium hydroxide / toluene / 55 °C
4.1: 4 h / 85 °C
5.1: sodium hydroxide / water / 1 h / 25 °C
5.2: Reflux
View Scheme
Multi-step reaction with 3 steps
1.1: phosphorus pentachloride / toluene / 2 h / Reflux
2.1: sodium hydroxide
2.2: 3 h / 90 °C
3.1: sodium hydroxide / tetrahydrofuran / 7 h / 50 - 65 °C
View Scheme
4-tert-butyl-N-(6-chloro-5-(2-methoxyphenoxy)2,2'-bipyrimidin-4-yl)benzene sulfonamide
150727-06-3

4-tert-butyl-N-(6-chloro-5-(2-methoxyphenoxy)2,2'-bipyrimidin-4-yl)benzene sulfonamide

bosentan
147536-97-8

bosentan

Conditions
ConditionsYield
In ethylene glycol
ethylene glycol
107-21-1

ethylene glycol

4-tert-butyl-N-(6-chloro-5-(2-methoxyphenoxy)2,2'-bipyrimidin-4-yl)benzene sulfonamide
150727-06-3

4-tert-butyl-N-(6-chloro-5-(2-methoxyphenoxy)2,2'-bipyrimidin-4-yl)benzene sulfonamide

A

p-tert-butyl-N-[6-hydroxy-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzenesulfonamide
174227-14-6

p-tert-butyl-N-[6-hydroxy-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzenesulfonamide

B

bosentan
147536-97-8

bosentan

Conditions
ConditionsYield
Stage #1: ethylene glycol With sodium hydroxide In tetrahydrofuran at 50℃; for 0.5h;
Stage #2: 4-tert-butyl-N-(6-chloro-5-(2-methoxyphenoxy)2,2'-bipyrimidin-4-yl)benzene sulfonamide In tetrahydrofuran at 50 - 65℃; for 12h;
bosentan barium

bosentan barium

bosentan
147536-97-8

bosentan

Conditions
ConditionsYield
With hydrogenchloride In dichloromethane; water pH=1 - 2; Product distribution / selectivity;
p-tert-butyl-N-[6-hydroxy-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzenesulfonamide
174227-14-6

p-tert-butyl-N-[6-hydroxy-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzenesulfonamide

2-chloro-ethanol
107-07-3

2-chloro-ethanol

bosentan
147536-97-8

bosentan

Conditions
ConditionsYield
Stage #1: p-tert-butyl-N-[6-hydroxy-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzenesulfonamide With sodium carbonate In N,N-dimethyl-formamide at 110 - 115℃; for 4h;
Stage #2: 2-chloro-ethanol In N,N-dimethyl-formamide for 16h;
Stage #3: With hydrogenchloride; water In N,N-dimethyl-formamide pH=2; Product distribution / selectivity;
Stage #1: p-tert-butyl-N-[6-hydroxy-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzenesulfonamide; 2-chloro-ethanol With potassium tert-butylate In N,N-dimethyl-formamide at 120℃; for 15h;
Stage #2: With hydrogenchloride; water In N,N-dimethyl-formamide at 20 - 25℃; pH=2;
Stage #1: p-tert-butyl-N-[6-hydroxy-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzenesulfonamide With sodium carbonate In dimethyl sulfoxide; toluene at 105 - 110℃;
Stage #2: 2-chloro-ethanol In dimethyl sulfoxide; toluene at 105 - 110℃;
Stage #3: With hydrogenchloride In water; dimethyl sulfoxide; toluene at 20℃;
bosentan hydrochloride
1196074-08-4

bosentan hydrochloride

bosentan
147536-97-8

bosentan

Conditions
ConditionsYield
With sodium hydrogencarbonate In ethanol; water for 2h; pH=7;
ethylene sulfite
3741-38-6

ethylene sulfite

p-tert-butyl-N-[6-hydroxy-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzenesulfonamide
174227-14-6

p-tert-butyl-N-[6-hydroxy-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzenesulfonamide

bosentan
147536-97-8

bosentan

Conditions
ConditionsYield
Stage #1: ethylene sulfite; p-tert-butyl-N-[6-hydroxy-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzenesulfonamide With potassium carbonate; tetrabutylammomium bromide In butanone Reflux;
Stage #2: With water; sodium hydroxide In ethyl acetate
N-(6-chloro-5-(2-methoxyphenoxy))-[2,2'-bipyrimidinyl]-4-t-butyl benzenesulfonamide cesium salt

N-(6-chloro-5-(2-methoxyphenoxy))-[2,2'-bipyrimidinyl]-4-t-butyl benzenesulfonamide cesium salt

ethylene glycol
107-21-1

ethylene glycol

bosentan
147536-97-8

bosentan

Conditions
ConditionsYield
Stage #1: ethylene glycol With sodium carbonate; dmap at 60 - 65℃; for 3h;
Stage #2: N-(6-chloro-5-(2-methoxyphenoxy))-[2,2'-bipyrimidinyl]-4-t-butyl benzenesulfonamide cesium salt In tetrahydrofuran for 135h; Product distribution / selectivity; Reflux;
4-tert-butyl-N-(6-chloro-5-(2-methoxyphenoxy)2,2'-bipyrimidin-4-yl)benzene sulfonamide
150727-06-3

4-tert-butyl-N-(6-chloro-5-(2-methoxyphenoxy)2,2'-bipyrimidin-4-yl)benzene sulfonamide

A

p-tert-butyl-N-[6-hydroxy-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzenesulfonamide
174227-14-6

p-tert-butyl-N-[6-hydroxy-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzenesulfonamide

B

bosentan
147536-97-8

bosentan

Conditions
ConditionsYield
In water; isopropyl alcohol at 115℃; for 5h;A 5.88 %Chromat.
B n/a
2-methoxy-phenol
90-05-1

2-methoxy-phenol

bosentan
147536-97-8

bosentan

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: sodium hydroxide / toluene / 20 °C / Reflux
1.2: 3.5 h / 60 °C / Reflux
2.1: sodium ethanolate / methanol / 6 h / 0 - 35 °C
3.1: trichlorophosphate / 4 h / 103 - 105 °C
3.2: 20 - 80 °C
4.1: potassium carbonate / tetrabutylammomium bromide / toluene / 2 h / Reflux
5.1: isopropyl alcohol; water / 5 h / 115 °C
View Scheme
Multi-step reaction with 6 steps
1.1: sodium hydroxide / toluene / 20 °C / Reflux
1.2: 3.5 h / 60 °C / Reflux
2.1: sodium ethanolate / methanol / 6 h / 0 - 35 °C
3.1: trichlorophosphate / 4 h / 103 - 105 °C
3.2: 20 - 80 °C
4.1: potassium carbonate / tetrabutylammomium bromide / toluene / 2 h / Reflux
5.1: water / 5 h / 115 °C
5.2: 1 h / 55 - 85 °C
6.1: hydrogenchloride / dichloromethane; water / 20 - 30 °C / pH 0.5 - 1
View Scheme
(2-methoxyphenoxy)-malonic acid dimethyl ester
150726-89-9

(2-methoxyphenoxy)-malonic acid dimethyl ester

bosentan
147536-97-8

bosentan

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: sodium ethanolate / methanol / 6 h / 0 - 35 °C
2.1: trichlorophosphate / 4 h / 103 - 105 °C
2.2: 20 - 80 °C
3.1: potassium carbonate / tetrabutylammomium bromide / toluene / 2 h / Reflux
4.1: isopropyl alcohol; water / 5 h / 115 °C
View Scheme
Multi-step reaction with 5 steps
1.1: sodium ethanolate / methanol / 6 h / 0 - 35 °C
2.1: trichlorophosphate / 4 h / 103 - 105 °C
2.2: 20 - 80 °C
3.1: potassium carbonate / tetrabutylammomium bromide / toluene / 2 h / Reflux
4.1: water / 5 h / 115 °C
4.2: 1 h / 55 - 85 °C
5.1: hydrogenchloride / dichloromethane; water / 20 - 30 °C / pH 0.5 - 1
View Scheme
Multi-step reaction with 6 steps
1.1: sodium methylate / methanol / 3 h / 25 - 30 °C
1.2: 3 h / 25 - 30 °C
2.1: trichlorophosphate / 4 h / Reflux
3.1: potassium hydroxide / acetone / 0.08 h / 30 °C
3.2: 6.5 h / 30 °C / Reflux
4.1: sodium hydride / N,N-dimethyl-formamide; mineral oil / 30 - 50 °C
4.2: 0.5 h / 30 °C
5.1: hydrogenchloride; water / 1 h
6.1: sodium tetrahydroborate; methanol / 4 h
View Scheme
pivaloyl chloride
3282-30-2

pivaloyl chloride

bosentan
147536-97-8

bosentan

2,2-dimethyl-propionic acid 2-[6-(4-tert-butyl-benzenesulfonylamino)-5-(2-methoxy-phenoxy)-[2,2']-bipyrimidinyl-4-yloxy]-ethyl ester
1374293-39-6

2,2-dimethyl-propionic acid 2-[6-(4-tert-butyl-benzenesulfonylamino)-5-(2-methoxy-phenoxy)-[2,2']-bipyrimidinyl-4-yloxy]-ethyl ester

Conditions
ConditionsYield
Stage #1: bosentan In dichloromethane at 20 - 25℃; for 1h;
Stage #2: pivaloyl chloride In dichloromethane at 20 - 25℃; for 15h;
97.5%
2,5-dihydroxybenzoic acid.
490-79-9

2,5-dihydroxybenzoic acid.

bosentan
147536-97-8

bosentan

N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-yl-pyrimidin-4-yl]-4-tert-butyl-benzenesulfonamide gentisic acid cocrystal
1450829-49-8

N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-yl-pyrimidin-4-yl]-4-tert-butyl-benzenesulfonamide gentisic acid cocrystal

Conditions
ConditionsYield
In n-heptane; acetone at 55℃; for 2.33333h; Concentration; Solvent; Temperature; Time; Sonication;96%
di(succinimido) carbonate
74124-79-1

di(succinimido) carbonate

bosentan
147536-97-8

bosentan

C32H32N6O10S

C32H32N6O10S

Conditions
ConditionsYield
In acetonitrile at 65℃; for 32h; Temperature; Solvent;95.5%
zinc(II) nitrate hexahydrate

zinc(II) nitrate hexahydrate

ethanol
64-17-5

ethanol

bosentan
147536-97-8

bosentan

C54H56N10O12S2Zn*2.5C2H6O

C54H56N10O12S2Zn*2.5C2H6O

Conditions
ConditionsYield
With potassium hydroxide for 4h; Thermodynamic data; Reflux;74%
maleic acid
110-16-7

maleic acid

bosentan
147536-97-8

bosentan

N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-yl-pyrimidin-4-yl]-4-tert-butyl-benzenesulfonamide maleic acid cocrystal

N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-yl-pyrimidin-4-yl]-4-tert-butyl-benzenesulfonamide maleic acid cocrystal

Conditions
ConditionsYield
In ethyl acetate; acetone at 4 - 80℃; for 12h; Concentration; Time; Temperature; Solvent;63%
In acetonitrile at 4 - 20℃;
pentafluorophenol 4-nitroxybutyrate
838878-70-9

pentafluorophenol 4-nitroxybutyrate

bosentan
147536-97-8

bosentan

C31H34N6O10S

C31H34N6O10S

Conditions
ConditionsYield
With dmap; triethylamine In dichloromethane at 0℃;57%
chloromethyl (4-(nitrooxy)butyl) carbonate
959639-85-1

chloromethyl (4-(nitrooxy)butyl) carbonate

bosentan
147536-97-8

bosentan

C33H38N6O12S

C33H38N6O12S

Conditions
ConditionsYield
With caesium carbonate In N,N-dimethyl-formamide for 48h;38%
1-chloro-ethyl 4-nitooxy-butyl carbonate
959639-82-8

1-chloro-ethyl 4-nitooxy-butyl carbonate

bosentan
147536-97-8

bosentan

C34H40N6O12S

C34H40N6O12S

Conditions
ConditionsYield
With caesium carbonate In N,N-dimethyl-formamide for 60h;30%
[4-(nitrooxy)methyl]benzoic acid pentafluorophenyl ester
874446-96-5

[4-(nitrooxy)methyl]benzoic acid pentafluorophenyl ester

bosentan
147536-97-8

bosentan

C35H34N6O10S

C35H34N6O10S

Conditions
ConditionsYield
With dmap; scandium tris(trifluoromethanesulfonate) In dichloromethane at 0℃;23%
4-(nitrooxy)butyl 4-nitrophenyl carbonate
935472-60-9

4-(nitrooxy)butyl 4-nitrophenyl carbonate

bosentan
147536-97-8

bosentan

C32H36N6O11S

C32H36N6O11S

Conditions
ConditionsYield
With dmap; scandium tris(trifluoromethanesulfonate) In dichloromethane at 0℃;15%
pyridine-2-carbonyl azide
4013-71-2

pyridine-2-carbonyl azide

bosentan
147536-97-8

bosentan

pyridin-2-ylcarbamic acid 2-[6-(4-tert-butyl-phenylsulfonylamino)-5-(2-methoxy-phenoxy)-2,2'-bipyrimidin-4-yloxy]-ethyl ester

pyridin-2-ylcarbamic acid 2-[6-(4-tert-butyl-phenylsulfonylamino)-5-(2-methoxy-phenoxy)-2,2'-bipyrimidin-4-yloxy]-ethyl ester

Conditions
ConditionsYield
With dmap In toluene at 100℃;

Bosentan Chemical Properties


Molecular Formula: C27H29N5O6S
Molar mass: 551.61 g/mol
Index of Refraction: 1.607
Molar Refractivity: 143.699 cm3
Molar Volume: 416.023 cm3
Surface Tension: 60.676 dyne/cm
Density: 1.326 g/cm3
Flash Point: 402.754 °C
Enthalpy of Vaporization: 113.612 kJ/mol
Boiling Point: 742.342 °C at 760 mmHg
Vapour Pressure: 0 mmHg at 25°C
Appearance: Pale yellow to off-White solid
Product categories of Bosentan (CAS NO.147536-97-8): Bases & Related Reagents ;Pharmaceuticals; Nucleotides
XLogP3-AA: 3.8
H-Bond Donor: 2
H-Bond Acceptor: 11
IUPAC Name: 4-Tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide
Canonical SMILES: CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC
InChI: InChI=1S/C27H29N5O6S/c1-27(2,3)18-10-12-19(13-11-18)39(34,35)32-23-22(38-21-9-6-5-8-20(21)36-4)26(37-17-16-33)31-25(30-23)24-28-14-7-15-29-24/h5-15,33H,16-17H2,1-4H3,(H,30,31,32) 
InChIKey: GJPICJJJRGTNOD-UHFFFAOYSA-N

Bosentan Uses

  Bosentan (CAS NO.147536-97-8) can be used for intermediates and is a fine Chemical.It is indicated mainly for the treatment of pulmonary hypertension, and has been approved in the European Union also for reducing the number of new digital ulcers in patients with systemic sclerosis and ongoing digital ulcer disease.In the United States,it is indicated for the treatment of pulmonary arterial hypertension in patients with WHO Class II-IV symptoms, to improve exercise capacity and decrease the rate of clinical worsening.

Bosentan Safety Profile

Experimental reproductive effects. When heated to decomposition it emits toxic vapors of NOx and SOx.

Bosentan Specification

  Bosentan (CAS NO.147536-97-8) can be called Tracleer ; 4-Tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl]benzenesulfonamide ; N-[6-(2-Hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-yl-pyrimidin-4-yl]-4-tert-butyl-benzenesulfonamide .It is a dual endothelin receptor antagonist important in the treatment of pulmonary artery hypertension (PAH). It is licensed in the European Union, the United States and other countries by Actelion Pharmaceuticals for the management of PAH under the trade name Tracleer.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View